ChemicalBook > CAS DataBase List > N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Product Name
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS No.
1092578-45-4
Chemical Name
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Synonyms
Tofatinib Impurity 22;Tofacitinib Impurity 130;N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-;N-((3R,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity）
CBNumber
CB23371620
Molecular Formula
C20H25N5
Formula Weight
335.45
MOL File
1092578-45-4.mol
More
Less

N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Property

Melting point:
75-77 °C
Density 
1.205±0.06 g/cm3(Predicted)
pka
13.36±0.50(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Suppliers

China 17 India 1 United States 1 Global 19
Standardpharm Co. Ltd.
Tel
86-714-3992388
Email
overseasales1@yongstandards.com
Country
United States
ProdList
14336
Advantage
58

1092578-45-4, N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amineRelated Search:

4-(Hydroxyamino)-4-oxobutanoic acid CYANOACETIC ACID-OSU N-Hydroxysuccinimide Tofacitinib Impurity 2 Ethyl S-4-chloro-3-hydroxybutyrate 2-amino-4-fluoro-5-nitrobenzoic acid TF-A (3R,4R)-N,4-dimethyl-piperidin-3-amine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine Tofacitinib Impurity 20 R-afatinib 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile Tofacitinib Impurity 19 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine

  • N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • Tofacitinib Impurity 130
  • N-((3R,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity）
  • 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-
  • Tofatinib Impurity 22
  • 1092578-45-4